The Cochrane Neonatal Editorial Board sets editorial priorities using multiple inputs and approaches.
The Editorial Board meets in person annually and meets via web conference quartlerly. Editorial priorities are considered during these meetings.
Annually, we conduct a Delphi process amongst our extended team of Senior Editors and Associate Editors/Peer Reviewers in order to prioritize reviews for updating. For this process, we consider all of our reviews which have not published within the last two years. Then we file these reviews based upon their usage (as determined by citation reports). We circulate the titles of the top 50 reviews to our team of experts and ask them to rank the top 10 reviews for updating based upon clinical need and the availability of potential new research.
Some new reviews and review updates have been funded through research grants. We seek grants to fund reviews of the highest importance to the neonatal community and to guideline developers. Once these grants are accepted, these reviews are prioritized to meet project deadlines.
We prioritize new reviews and review updates as new research arises. We also prioritize reviews when they have been requested by guideline development groups.
Engagement with the Neonatal Community
We encourage caregivers and parents in the neonatal community to also provide input for our work. Please click here to provide input.
2019 Priority Reviews
- Network meta-analysis of corticosteroids for the prevention and treatment of bronchopulmonary dysplasia*
- Preterm formula milk versus term formula milk for feeding preterm or low birth weight infants*
- Banked preterm versus banked term human milk to promote growth and development in very low birth weight infants*
- Dilute versus full strength formula in exclusively formula-fed preterm or low birth weight infants*
- Formula milk versus maternal breast milk for feeding preterm or low birth weight infants*
- Formula versus donor breast milk for feeding preterm or low birth weight infants*
- Protein hydrolysate versus standard formula for preterm infants*
- Prophylactic vitamin K for vitamin K deficiency bleeding in neonates
- Probiotics for prevention of necrotizing enterocolitis in preterm infants
- Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants
- Cooling for newborns with hypoxic ischaemic encephalopathy
- Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants
- Air versus oxygen for resuscitation of infants at birth
- Anticonvulsants for neonates with seizures (replaced by Anti-epileptic therapy to reduce mortality and neuro-developmental disability in neonates with seizures)
- Nasal continuous positive airway pressure immediately after extubation for preventing morbidity in preterm infants
- Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants
- Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants
- High flow nasal cannula for respiratory support in preterm infants